DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, DaVita Inc. (DVA) trades at a P/E ratio of 15.0×. Over the past ten years it has ranged from 8.5× (August 2017) to 78.1× (May 2019); the current reading is higher than 41% of that period. That is below the Medical Care Facilities industry median of 20.6× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 11.2× (17.20%)
FY2024 13.6× (3.47%)
FY2023 14.0× 12.23%
FY2022 12.5× 2.09%
FY2021 12.3× (32.76%)
FY2020 18.2× 30.72%
FY2019 13.9× (77.24%)
FY2018 61.3× 196.43%
FY2017 20.7× 38.12%
FY2016 15.0× (72.74%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 17.8× 27.59%
Mar 2026 14.0× 24.46%
Dec 2025 11.2× (16.02%)
Sep 2025 13.4× (2.32%)
42 more quarters

Against its own ten years

Low 8.5× High 78.1×
Ten-year median 16.1×
Current reading's percentile 45

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DVA